Keratocan

Keratocan is a protein that in humans is encoded by the KERA gene. It is a significant component of the cornea, playing a crucial role in its structure and function. Keratocan belongs to the small leucine-rich proteoglycan (SLRP) family, which is essential in the development and maintenance of various tissues, including the cornea, bone, and skin.

Function

Keratocan is primarily found in the corneal stroma, where it contributes to the transparency and refractive properties of the cornea. It does so by regulating the arrangement and uniform spacing of collagen fibrils. The precise spacing of these fibrils is critical for the cornea's transparency, as it allows light to pass through without scattering. Keratocan also plays a role in corneal development and thickness, influencing the eye's ability to focus light accurately.

Genetics

The KERA gene is located on the long (q) arm of chromosome 12 at position 22.1, more precisely at 12q22. Mutations in this gene have been associated with corneal diseases such as corneal dystrophy and keratoconus. These conditions can lead to visual impairment or loss due to the disruption of the cornea's normal structure and function.

Clinical Significance

1. 1. 1. Corneal Dystrophies

Mutations in the KERA gene can lead to several types of corneal dystrophies, which are a group of genetic, often bilateral, progressive corneal diseases. These dystrophies are characterized by the accumulation of abnormal material in the cornea, leading to its opacification and loss of transparency.

1. 1. 1. Keratoconus

Keratoconus is a degenerative disorder characterized by thinning and conical deformation of the cornea. While the exact cause of keratoconus is not fully understood, genetic factors, including mutations in the KERA gene, have been implicated in its development. This condition can significantly affect vision by inducing irregular astigmatism and myopia.

Diagnosis and Treatment

Diagnosis of conditions related to KERA gene mutations involves a comprehensive eye examination, including visual acuity tests, corneal topography, and genetic testing. Treatment options vary depending on the specific condition and its severity but may include glasses or contact lenses to correct vision, corneal collagen cross-linking to strengthen the cornea, or corneal transplantation in advanced cases.

Research Directions

Ongoing research aims to further elucidate the role of keratocan in corneal health and disease. This includes studies on the molecular mechanisms underlying its function, the development of gene therapies to correct mutations in the KERA gene, and the exploration of novel treatments for corneal dystrophies and keratoconus.